NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Price, News & Analysis

$1.53
+0.02 (+0.99%)
(As of 01:40 PM ET)
Today's Range
$1.50
$1.55
50-Day Range
$1.26
$1.71
52-Week Range
$1.16
$6.24
Volume
24,461 shs
Average Volume
214,591 shs
Market Capitalization
$44.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Rockwell Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
357.5% Upside
$7.00 Price Target
Short Interest
Healthy
2.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.59mentions of Rockwell Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.11) to $0.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.75 out of 5 stars

Medical Sector

225th out of 910 stocks

Pharmaceutical Preparations Industry

89th out of 426 stocks

RMTI stock logo

About Rockwell Medical Stock (NASDAQ:RMTI)

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Stock Price History

RMTI Stock News Headlines

Rockwell Medical, Inc. (RMTI)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Q4 2023 Rockwell Medical Inc Earnings Call
Rockwell Medical: Q4 Earnings Insights
Rockwell Medical: Q4 Earnings Snapshot
Rockwell Medical earnings preview: what Wall Street is expecting
Rockwell Medical Inc RMTI
Returning To Rockwell Medical: Buy At 65% Of Revenue
See More Headlines
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
4/23/2024
Next Earnings (Confirmed)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:RMTI
CUSIP
77437410
Employees
237
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$9.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+362.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-8,440,000.00
Pretax Margin
-10.09%

Debt

Sales & Book Value

Annual Sales
$83.61 million
Cash Flow
$0.02 per share
Book Value
$0.75 per share

Miscellaneous

Free Float
28,719,000
Market Cap
$44.48 million
Optionable
Optionable
Beta
1.17

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Dr. Mark Strobeck Ph.D. (Age 53)
    President, CEO & Director
    Comp: $643.41k
  • Ms. Megan C. Timmins (Age 51)
    Executive VP, Chief Legal Officer & Secretary
    Comp: $518.09k
  • Mr. James A. McCarthy
    Senior Vice President of Business & Corporate Development
  • Mr. Timothy T. Chole
    Senior Vice President of Sales & Marketing
  • Ms. Heather R. Hunter
    Senior VP & Chief Corporate Affairs Officer
  • Mr. Jason Finkelstein
    Investor Relations Representative

RMTI Stock Analysis - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings
or view top-rated stocks.

What is Rockwell Medical's stock price target for 2024?

2 brokerages have issued 12-month price objectives for Rockwell Medical's shares. Their RMTI share price targets range from $5.00 to $9.00. On average, they predict the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 357.5% from the stock's current price.
View analysts price targets for RMTI
or view top-rated stocks among Wall Street analysts.

How have RMTI shares performed in 2024?

Rockwell Medical's stock was trading at $1.89 at the beginning of 2024. Since then, RMTI stock has decreased by 19.0% and is now trading at $1.53.
View the best growth stocks for 2024 here
.

When is Rockwell Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our RMTI earnings forecast
.

How can I listen to Rockwell Medical's earnings call?

Rockwell Medical will be holding an earnings conference call on Tuesday, May 14th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings data on Thursday, March, 21st. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.10. The business earned $22.09 million during the quarter, compared to analysts' expectations of $22.09 million. Rockwell Medical had a negative net margin of 10.09% and a negative trailing twelve-month return on equity of 39.17%.

When did Rockwell Medical's stock split?

Rockwell Medical shares reverse split on the morning of Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $84.0 million-$88.0 million, compared to the consensus revenue estimate of $98.0 million.

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).

How do I buy shares of Rockwell Medical?

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RMTI) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners